Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama decreased its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 3.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,113 shares of the company’s stock after selling 1,646 shares during the period. Retirement Systems of Alabama’s holdings in Bath & Body Works were worth $2,163,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Front Row Advisors LLC acquired a new position in Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont acquired a new position in Bath & Body Works during the third quarter worth about $27,000. Denali Advisors LLC acquired a new position in Bath & Body Works during the fourth quarter worth about $27,000. GAMMA Investing LLC acquired a new position in Bath & Body Works during the fourth quarter worth about $27,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in Bath & Body Works during the fourth quarter worth about $35,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insiders Place Their Bets

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares in the company, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is owned by insiders.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $47.62 on Thursday. Bath & Body Works, Inc. has a 1 year low of $27.30 and a 1 year high of $50.34. The firm has a 50 day moving average price of $46.08 and a 200 day moving average price of $41.38. The company has a market cap of $10.71 billion, a price-to-earnings ratio of 12.37, a PEG ratio of 1.49 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. During the same period in the previous year, the firm earned $1.86 earnings per share. Bath & Body Works’s revenue for the quarter was up .8% on a year-over-year basis. Sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.68%. Bath & Body Works’s dividend payout ratio is currently 20.78%.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of research reports. Robert W. Baird lifted their target price on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Evercore ISI boosted their price objective on shares of Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a research report on Friday, March 1st. The Goldman Sachs Group boosted their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, March 4th. TD Cowen boosted their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, Wells Fargo & Company boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 24th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $46.73.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.